Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan
Viruses · 2024
DOI: 10.3390/v16060962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Abdur Rashid und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin 300071, China. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Drug Resistance, Viral, Genetic Variation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation International/Inter-Organization Cooperation and Exchange Study-NSFC-VR Project (China and Switzerland), State Key Laboratory of Infections Disease Prevention and Control, the Ministry of Science and Technology of China, the National Natural Science Foundation International/Inter-Organization Cooperation and Exchange Study-NSFC-VR Project (China and Switzerland).
Abstract (Originalsprache)
The human immunodeficiency virus type-1 epidemic in Pakistan has significantly increased over the last two decades. In Karachi, Pakistan, there is a lack of updated information on the complexity of HIV-1 genetic diversity and the burden of drug resistance mutations (DRMs) that can contribute to ART failure and poor treatment outcomes. This study aimed to determine HIV-1 genetic diversity and identify drug-resistance mutations among people living with HIV in Karachi. A total of 364 HIV-positive individuals, with a median age of 36 years, were enrolled in the study. The HIV-1 partial pol gene was successfully sequenced from 268 individuals. The sequences were used to generate phylogenetic trees to determine clade diversity and also to assess the burden of DRMs. Based on the partial pol sequences, 13 distinct HIV-1 subtypes and recombinant forms were identified. Subtype A1 was the most common clade (40%), followed by CRF02_AG (33.2%). Acquired DRMs were found in 30.6% of the ART-experienced patients, of whom 70.7%, 20.7%, and 8.5% were associated with resistance to NNRTIs, NRTIs, and PIs, respectively. Transmitted DRMs were found in 5.6% of the ART-naïve patients, of whom 93% were associated with resistance against NNRTIs and 7% to PIs. The high prevalence of DRMs in ART-experienced patients poses significant challenges to the long-term benefits and sustainability of the ART program. This study emphasizes the importance of continuous HIV molecular epidemiology and drug resistance surveillance to support evidence-based HIV prevention, precise ART, and targeted AIDS care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Nankai University, Tianjin 300071, China.
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
- College of Life Sciences, Nankai University, Tianjin 300071, China.
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The…
- Bridge Consultants Foundation, Karachi 75100, Pakistan.
- Department of Medicine, Aga Khan University, Karachi 74800, Pakistan.
ORCID-Profile: Abdur Rashid, Syed Faisal Mahmood, Yimam Getaneh, Syed Hani Abidi, Yiming Shao
Förderung
- National Natural Science Foundation International/Inter-Organization Cooperation and Exchange Study-NSFC-VR Project (China and Switzerland)
- State Key Laboratory of Infections Disease Prevention and Control, the Ministry of Science and Technology of China
- the National Natural Science Foundation International/Inter-Organization Cooperation and Exchange Study-NSFC-VR Project (China and Switzerland)
Zitieren
APA
Rashid, A., Kang, L., Yi, F., Chu, Q., Shah, S. A., Mahmood, S. F., Getaneh, Y., Wei, M., Chang, S., Abidi, S. H., & Shao, Y. (2024). Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan. Viruses. https://doi.org/10.3390/v16060962
Vancouver
Rashid A, Kang L, Yi F, Chu Q, Shah SA, Mahmood SF, et al. Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan. Viruses. 2024. doi:10.3390/v16060962
BibTeX
@article{Rashid2024,
author = {Rashid, Abdur and Kang, Li and Yi, Feng and Chu, Qingfei and Shah, Sharaf Ali and Mahmood, Syed Faisal and Getaneh, Yimam and Wei, Min and Chang, Song and Abidi, Syed Hani and Shao, Yiming},
title = {Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16060962}
}
EUVIMED